Efficacy of Once-Daily Versus Twice-Daily Mesalazine ( Pentasa®): Sub-Analysis of the Left-Sided Colitis Population in the Randomised PODIUM Trial

被引：0
|
作者：
Vermeire, Severine
Befrits, Ragnar
Bokemeyer, Bernd
Gill, Ivo
Hommes, Daniel W.
Broberg, Per
Dignass, Axel U.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1254
引用
收藏
页码：S522 / S522
页数：1
相关论文
共 50 条
  • [1] Efficacy of once-daily versus twice-daily mesalazine (PENTAS®): sub-analysis of the left-sided colitis population in the randomised PODIUM trial
    Befrits, Ragnar
    Bokemeyer, Bernd
    Gill, Ivo
    Hommes, Daan
    Broberg, Per
    Dignass, Axel
    Severine, Vermeire
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 72 - 73
  • [2] Treatment acceptability in a randomised controlled trial of once-daily or twice-daily mesalazine (Pentasa) for the maintenance of remission in ulcerative colitis
    Dignass, Axel U.
    Bokemeyer, Bernd
    Adamek, H. E.
    Mross, Michael R.
    Vinter-Jensen, Lars
    Boerner, N.
    Silvennoinen, Jouni
    Tan, T. G.
    Oudkerk-Pool, M.
    Stijnen, Theo
    Dietel, Peter
    Klugmann, Tobias
    Veerman, Henri
    GASTROENTEROLOGY, 2008, 134 (04) : A495 - A496
  • [3] The PODIUM trial of once-daily versus twice-daily mesalazine dosing in ulcerative colitis: maintenance of mucosal healing
    Lukas, Milan
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Oudkerk Marco
    Befrits, Ragnar
    Broberg, Per
    Dignass, Axel
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 74 - 74
  • [4] The PODIUM Trial of Once-Daily Versus Twice-Daily Mesalazine Dosing in Ulcerative Colitis: Maintenance of Mucosal Healing
    Dignass, Axel U.
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Marco Oudkerk
    Befrits, Ragnar
    Broberg, Per
    Lukas, Milan
    GASTROENTEROLOGY, 2010, 138 (05) : S520 - S520
  • [5] Once-versus twice-daily mesalazine (pentasa) granules for the maintenance of remission in ulcerative colitis: Results from a multinational randomised controlled trial
    Dignass, A.
    Veerman, H.
    GUT, 2008, 57 : A1 - A1
  • [6] Impact of Once - Daily Versus Twice-Daily Mesalazine (Pentasa) On Relief of Rectal Bleeding and Stool Frequency: Results from a Multinational Randomised Controlled Trial
    Dignass, Axel U.
    Bokemeyer, Bernd
    Stijnen, Theo
    Veerman, Henri
    GASTROENTEROLOGY, 2009, 136 (05) : A685 - A685
  • [7] Once-Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
    Turner, Dan
    Yerushalmi, Baruch
    Kori, Michal
    Broide, Efrat
    Mozer-Glassberg, Yael
    Shaoul, Ron
    Kolho, Kaija-Leena
    Shteyer, Eyal
    Shamaly, Hussein
    Ledder, Oren
    Cohen, Shlomi
    Peleg, Sarit
    On, Avi
    Levine, Arie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 527 - 533
  • [8] Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Schreiber, S.
    Lees, K.
    Barrett, K.
    Joseph, R.
    GUT, 2008, 57 (07) : 893 - 902
  • [9] Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
    Flourie, Bernard
    Hagege, Herve
    Tucat, Gilbert
    Masclee, Ad
    Dewit, Olivier
    Probert, Chris
    Broberg, Per
    Djamila, Aoucheta
    GASTROENTEROLOGY, 2012, 142 (05) : S197 - S197
  • [10] COMPARATIVE EFFICACY OF ONCE-DAILY VERSUS TWICE-DAILY PRAVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
    PAN, HY
    DEVAULT, AR
    BRESCIA, D
    WILLARD, DA
    CLINICAL THERAPEUTICS, 1991, 13 (03) : 368 - 372
12345